Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery

by Dirk Bald, Cristina Villellas, Ping Lu, Anil Koul, Eric J. Rubin, R. John Collier
Published 2017-04-01

The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd

by Ping Lu, Amer H. Asseri, Martijn Kremer, Janneke Maaskant, Roy Ummels, Holger Lill, Dirk Bald
Published 2018-02-01

Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.

by Anna C Haagsma, Ioana Podasca, Anil Koul, Koen Andries, Jerome Guillemont, Holger Lill, Dirk Bald
Published 2011-01-01

Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo 3 solubilized in dodecyl-maltoside

by Amer H. Asseri, Albert Godoy-Hernandez, Hojjat Ghasemi Goojani, Holger Lill, Junshi Sakamoto, Duncan G. G. McMillan, Dirk Bald
Published 2021-04-01